These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate. Moore EC; Friedman J; Valdivieso M; Plunkett W; Marti JR; Russ J; Loo TL Biochem Pharmacol; 1982 Oct; 31(20):3317-21. PubMed ID: 7150358 [TBL] [Abstract][Full Text] [Related]
3. A 70-amino acid zinc-binding polypeptide fragment from the regulatory chain of aspartate transcarbamoylase causes marked changes in the kinetic mechanism of the catalytic trimer. Zhou BB; Waldrop GL; Lum L; Schachman HK Protein Sci; 1994 Jun; 3(6):967-74. PubMed ID: 8069226 [TBL] [Abstract][Full Text] [Related]
4. Measurement of aspartate carbamoyltransferase activity by high performance liquid chromatography. Grem JL; Drake JC; Allegra CJ Anticancer Drugs; 1993 Oct; 4(5):545-54. PubMed ID: 8292811 [TBL] [Abstract][Full Text] [Related]
5. Regulatory kinetics of wheat-germ aspartate transcarbamoylase. Adaptation of the concerted model to account for complex kinetic effects of uridine 5'-monophosphate. Yon RJ Biochem J; 1984 Jul; 221(2):281-7. PubMed ID: 6477473 [TBL] [Abstract][Full Text] [Related]
6. N-(Phosphonacetyl)-L-aspartate inhibition of the enzyme complex of pyrimidine biosynthesis. Moore EC Biochem Pharmacol; 1982 Oct; 31(20):3313-6. PubMed ID: 7150357 [TBL] [Abstract][Full Text] [Related]
7. A novel mechanism for resistance to the antimetabolite N-phosphonoacetyl-L-aspartate by Helicobacter pylori. Burns BP; Mendz GL; Hazell SL J Bacteriol; 1998 Nov; 180(21):5574-9. PubMed ID: 9791105 [TBL] [Abstract][Full Text] [Related]
8. The allosteric activator ATP induces a substrate-dependent alteration of the quaternary structure of a mutant aspartate transcarbamoylase impaired in active site closure. Baker DP; Fetler L; Vachette P; Kantrowitz ER Protein Sci; 1996 Nov; 5(11):2276-86. PubMed ID: 8931146 [TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structure of carbamoyl phosphate and succinate bound to aspartate carbamoyltransferase. Gouaux JE; Lipscomb WN Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4205-8. PubMed ID: 3380787 [TBL] [Abstract][Full Text] [Related]
10. Changes in the hydrogen exchange kinetics of Escherichia coli aspartate transcarbamylase produced by effector binding and subunit association. Lennick M; Allewell NM Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6759-63. PubMed ID: 7031660 [TBL] [Abstract][Full Text] [Related]
11. Importance of domain closure for homotropic cooperativity in Escherichia coli aspartate transcarbamylase. Newton CJ; Kantrowitz ER Biochemistry; 1990 Feb; 29(6):1444-51. PubMed ID: 2185840 [TBL] [Abstract][Full Text] [Related]
12. Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity. Kensler TW; Erlichman C; Jayaram HN; Tyagi AK; Ardalan B; Cooney DA Cancer Treat Rep; 1980; 64(8-9):967-73. PubMed ID: 7448831 [TBL] [Abstract][Full Text] [Related]
13. Function of threonine-55 in the carbamoyl phosphate binding site of Escherichia coli aspartate transcarbamoylase. Xu W; Kantrowitz ER Biochemistry; 1989 Dec; 28(26):9937-43. PubMed ID: 2515892 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875 [TBL] [Abstract][Full Text] [Related]
15. 13C isotope effect studies of Escherichia coli aspartate transcarbamylase in the presence of the bisubstrate analog N-(phosphonoacetyl)-L-aspartate. Parmentier LE; O'Leary MH; Schachman HK; Cleland WW Biochemistry; 1992 Jul; 31(28):6598-602. PubMed ID: 1633172 [TBL] [Abstract][Full Text] [Related]
16. Aspartate transcarbamylase from Leishmania donovani. A discrete, nonregulatory enzyme as a potential chemotherapeutic site. Mukherjee T; Ray M; Bhaduri A J Biol Chem; 1988 Jan; 263(2):708-13. PubMed ID: 2891701 [TBL] [Abstract][Full Text] [Related]
17. Importance of residues Arg-167 and Gln-231 in both the allosteric and catalytic mechanisms of Escherichia coli aspartate transcarbamoylase. Stebbins JW; Zhang Y; Kantrowitz ER Biochemistry; 1990 Apr; 29(16):3821-7. PubMed ID: 2191720 [TBL] [Abstract][Full Text] [Related]
18. Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells. White JC; Hines LH Biochem Pharmacol; 1984 Nov; 33(22):3645-8. PubMed ID: 6508821 [TBL] [Abstract][Full Text] [Related]
20. Glu-50 in the catalytic chain of Escherichia coli aspartate transcarbamoylase plays a crucial role in the stability of the R quaternary structure. Tauc P; Keiser RT; Kantrowitz ER; Vachette P Protein Sci; 1994 Nov; 3(11):1998-2004. PubMed ID: 7703847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]